{"id":"https://openalex.org/W2000303477","doi":"https://doi.org/10.1016/s0168-3659(97)00210-1","title":"Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer\u2013doxorubicin conjugates directed against different T-cell surface antigens","display_name":"Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer\u2013doxorubicin conjugates directed against different T-cell surface antigens","alternate_titles":[],"publication_year":1998,"publication_date":"1998-03-01","ids":{"openalex":"https://openalex.org/W2000303477","doi":"https://doi.org/10.1016/s0168-3659(97)00210-1","mag":"2000303477","pmid":"https://pubmed.ncbi.nlm.nih.gov/9743446"},"language":"en","primary_location":{"id":"doi:10.1016/s0168-3659(97)00210-1","doi":"https://doi.org/10.1016/s0168-3659(97)00210-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0168-3659(97)00210-1","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000303477"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110145949","display_name":"Mark\u00e9ta Jel\u00ednkov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122847","display_name":"Czech Academy of Sciences, Institute of Microbiology","ror":"https://ror.org/02p1jz666","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210122847"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"M Jel\u0131\u0301nkov\u00e1","raw_affiliation_strings":["Institute of Microbiology AS CR, 142 20 Prague 4, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbiology AS CR, 142 20 Prague 4, Czech Republic","institution_ids":["https://openalex.org/I4210122847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111815289","display_name":"Ji\u0159\u00ed Strohalm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101964","display_name":"Czech Academy of Sciences, Institute of Macromolecular Chemistry","ror":"https://ror.org/0143w7709","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210101964"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"J Strohalm","raw_affiliation_strings":["Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic","institution_ids":["https://openalex.org/I4210101964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113663567","display_name":"D Plocov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101964","display_name":"Czech Academy of Sciences, Institute of Macromolecular Chemistry","ror":"https://ror.org/0143w7709","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210101964"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"D Plocov\u00e1","raw_affiliation_strings":["Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic","institution_ids":["https://openalex.org/I4210101964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061590219","display_name":"Vladim\u00edr \u0160ubr","orcid":"https://orcid.org/0000-0002-1614-6595","observed_orcids":["https://orcid.org/0000-0002-1614-6595"]},"institutions":[{"id":"https://openalex.org/I4210101964","display_name":"Czech Academy of Sciences, Institute of Macromolecular Chemistry","ror":"https://ror.org/0143w7709","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210101964"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"V \u0160ubr","raw_affiliation_strings":["Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic","institution_ids":["https://openalex.org/I4210101964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039083338","display_name":"Martin \u0160\u0165astn\u00fd","orcid":"https://orcid.org/0000-0003-1017-6491","observed_orcids":["https://orcid.org/0000-0003-1017-6491"]},"institutions":[{"id":"https://openalex.org/I4210122847","display_name":"Czech Academy of Sciences, Institute of Microbiology","ror":"https://ror.org/02p1jz666","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210122847"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"M \u0160t'astn\u00fd","raw_affiliation_strings":["Institute of Microbiology AS CR, 142 20 Prague 4, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbiology AS CR, 142 20 Prague 4, Czech Republic","institution_ids":["https://openalex.org/I4210122847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040270800","display_name":"Karel Ulbrich","orcid":"https://orcid.org/0000-0003-2174-9654","observed_orcids":["https://orcid.org/0000-0003-2174-9654"]},"institutions":[{"id":"https://openalex.org/I4210101964","display_name":"Czech Academy of Sciences, Institute of Macromolecular Chemistry","ror":"https://ror.org/0143w7709","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210101964"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"K Ulbrich","raw_affiliation_strings":["Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Macromolecular Chemistry AS CR, 162 06 Prague 6, Czech Republic","institution_ids":["https://openalex.org/I4210101964"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109032097","display_name":"B \u0158\u00edhov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122847","display_name":"Czech Academy of Sciences, Institute of Microbiology","ror":"https://ror.org/02p1jz666","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210122847"]}],"countries":["CZ"],"is_corresponding":true,"raw_author_name":"B \u0158\u0131\u0301hov\u00e1","raw_affiliation_strings":["Institute of Microbiology AS CR, 142 20 Prague 4, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbiology AS CR, 142 20 Prague 4, Czech Republic","institution_ids":["https://openalex.org/I4210122847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109032097"],"corresponding_institution_ids":["https://openalex.org/I4210122847"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":null,"fwci":2.7967,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.89025178,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"52","issue":"3","first_page":"253","last_page":"270"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9413999915122986,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.020800000056624413,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8199999928474426},{"id":"https://openalex.org/keywords/hpma-copolymer","display_name":"HPMA copolymer","score":0.890999972820282},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cd4","display_name":"CD4","score":0.6919999718666077},{"id":"https://openalex.org/keywords/il-2-receptor","display_name":"interleukin-2 receptor","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.9900000095367432},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/con-a-stimulation","display_name":"Con A stimulation","score":0.6449999809265137},{"id":"https://openalex.org/keywords/el4-lymphoma","display_name":"EL4 lymphoma","score":0.5950000286102295},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.656000018119812},{"id":"https://openalex.org/keywords/drug-release-kinetics","display_name":"drug release kinetics","score":0.718999981880188},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6874445676803589},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5648949146270752},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5475630760192871},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5470110774040222},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5446155071258545},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5337565541267395},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5095017552375793},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4977758228778839},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4687006175518036},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4652920961380005},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4330432415008545},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.42872875928878784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3158697187900543},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23239794373512268},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23013433814048767},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22161856293678284},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0745505690574646},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000954","descriptor_name":"Antigens, Surface","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003208","descriptor_name":"Concanavalin A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011109","descriptor_name":"Polymethacrylic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0168-3659(97)00210-1","doi":"https://doi.org/10.1016/s0168-3659(97)00210-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0168-3659(97)00210-1","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},{"id":"pmid:9743446","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9743446","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of controlled release : official journal of the Controlled Release Society","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W7648716","https://openalex.org/W34750704","https://openalex.org/W84849991","https://openalex.org/W147746226","https://openalex.org/W239028972","https://openalex.org/W1515284656","https://openalex.org/W1535486835","https://openalex.org/W1540826012","https://openalex.org/W1586481015","https://openalex.org/W1630241296","https://openalex.org/W1710740437","https://openalex.org/W1871308790","https://openalex.org/W1907325355","https://openalex.org/W1919135136","https://openalex.org/W1936753325","https://openalex.org/W1938889768","https://openalex.org/W1959625971","https://openalex.org/W1972678792","https://openalex.org/W1979851400","https://openalex.org/W1979995732","https://openalex.org/W1983387455","https://openalex.org/W1983697215","https://openalex.org/W1991960832","https://openalex.org/W2001851637","https://openalex.org/W2003763258","https://openalex.org/W2007665833","https://openalex.org/W2017142317","https://openalex.org/W2026029468","https://openalex.org/W2031366715","https://openalex.org/W2031644592","https://openalex.org/W2041535998","https://openalex.org/W2059212524","https://openalex.org/W2061294880","https://openalex.org/W2066992444","https://openalex.org/W2077367574","https://openalex.org/W2080761735","https://openalex.org/W2082477193","https://openalex.org/W2084093106","https://openalex.org/W2088501009","https://openalex.org/W2092639730","https://openalex.org/W2097038382","https://openalex.org/W2099086927","https://openalex.org/W2109828871","https://openalex.org/W2112824007","https://openalex.org/W2124887915","https://openalex.org/W2137853738","https://openalex.org/W2155062060","https://openalex.org/W2155361063","https://openalex.org/W2157166246","https://openalex.org/W2168350093","https://openalex.org/W2169550493","https://openalex.org/W2175948629","https://openalex.org/W2320751441","https://openalex.org/W2415998525","https://openalex.org/W2418396119","https://openalex.org/W2473532150","https://openalex.org/W2905244560","https://openalex.org/W2912584980","https://openalex.org/W4245535318","https://openalex.org/W6639955116"],"related_works":["https://openalex.org/W177690167","https://openalex.org/W1981290008","https://openalex.org/W2060974519","https://openalex.org/W2063985611","https://openalex.org/W1586481015","https://openalex.org/W2061294880","https://openalex.org/W88713093","https://openalex.org/W2146531326","https://openalex.org/W2046411724","https://openalex.org/W2057521541"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000303477","counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
